nodes	percent_of_prediction	percent_of_DWPC	metapath
Guaifenesin—Calculus of kidney—Bicalutamide—prostate cancer	0.046	0.0497	CcSEcCtD
Guaifenesin—Nephrolithiasis—Bicalutamide—prostate cancer	0.0375	0.0405	CcSEcCtD
Guaifenesin—Discomfort—Abiraterone—prostate cancer	0.0168	0.0181	CcSEcCtD
Guaifenesin—Discomfort—Nilutamide—prostate cancer	0.0153	0.0166	CcSEcCtD
Guaifenesin—Discomfort—Flutamide—prostate cancer	0.0153	0.0165	CcSEcCtD
Guaifenesin—Carvedilol—GJA1—prostate cancer	0.014	0.188	CrCbGaD
Guaifenesin—Discomfort—Degarelix—prostate cancer	0.0137	0.0148	CcSEcCtD
Guaifenesin—Discomfort—Cabazitaxel—prostate cancer	0.0129	0.0139	CcSEcCtD
Guaifenesin—Urticaria—Estrone—prostate cancer	0.0127	0.0138	CcSEcCtD
Guaifenesin—Urticaria—Estradiol valerate/Dienogest—prostate cancer	0.0111	0.012	CcSEcCtD
Guaifenesin—Vomiting—Estramustine—prostate cancer	0.0107	0.0115	CcSEcCtD
Guaifenesin—Dizziness—Estrone—prostate cancer	0.0106	0.0114	CcSEcCtD
Guaifenesin—Rash—Estramustine—prostate cancer	0.0106	0.0114	CcSEcCtD
Guaifenesin—Carvedilol—HIF1A—prostate cancer	0.0106	0.143	CrCbGaD
Guaifenesin—Dermatitis—Estramustine—prostate cancer	0.0106	0.0114	CcSEcCtD
Guaifenesin—Urticaria—Degarelix—prostate cancer	0.0106	0.0114	CcSEcCtD
Guaifenesin—Headache—Estramustine—prostate cancer	0.0105	0.0114	CcSEcCtD
Guaifenesin—Vomiting—Abiraterone—prostate cancer	0.0104	0.0112	CcSEcCtD
Guaifenesin—Rash—Abiraterone—prostate cancer	0.0103	0.0111	CcSEcCtD
Guaifenesin—Dermatitis—Abiraterone—prostate cancer	0.0103	0.0111	CcSEcCtD
Guaifenesin—Vomiting—Estrone—prostate cancer	0.0102	0.011	CcSEcCtD
Guaifenesin—Rash—Estrone—prostate cancer	0.0101	0.0109	CcSEcCtD
Guaifenesin—Dermatitis—Estrone—prostate cancer	0.0101	0.0109	CcSEcCtD
Guaifenesin—Headache—Estrone—prostate cancer	0.01	0.0108	CcSEcCtD
Guaifenesin—Nausea—Estramustine—prostate cancer	0.00997	0.0108	CcSEcCtD
Guaifenesin—Dizziness—Nilutamide—prostate cancer	0.00984	0.0106	CcSEcCtD
Guaifenesin—Dizziness—Flutamide—prostate cancer	0.0098	0.0106	CcSEcCtD
Guaifenesin—Nausea—Estrone—prostate cancer	0.00952	0.0103	CcSEcCtD
Guaifenesin—Vomiting—Nilutamide—prostate cancer	0.00947	0.0102	CcSEcCtD
Guaifenesin—Vomiting—Flutamide—prostate cancer	0.00942	0.0102	CcSEcCtD
Guaifenesin—Rash—Nilutamide—prostate cancer	0.00939	0.0101	CcSEcCtD
Guaifenesin—Dermatitis—Nilutamide—prostate cancer	0.00938	0.0101	CcSEcCtD
Guaifenesin—Discomfort—Ethinyl Estradiol—prostate cancer	0.00936	0.0101	CcSEcCtD
Guaifenesin—Rash—Flutamide—prostate cancer	0.00934	0.0101	CcSEcCtD
Guaifenesin—Dermatitis—Flutamide—prostate cancer	0.00934	0.0101	CcSEcCtD
Guaifenesin—Headache—Nilutamide—prostate cancer	0.00933	0.0101	CcSEcCtD
Guaifenesin—Headache—Flutamide—prostate cancer	0.00928	0.01	CcSEcCtD
Guaifenesin—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.00925	0.00999	CcSEcCtD
Guaifenesin—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.00889	0.00961	CcSEcCtD
Guaifenesin—Nausea—Nilutamide—prostate cancer	0.00884	0.00955	CcSEcCtD
Guaifenesin—Rash—Estradiol valerate/Dienogest—prostate cancer	0.00882	0.00953	CcSEcCtD
Guaifenesin—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.00881	0.00952	CcSEcCtD
Guaifenesin—Nausea—Flutamide—prostate cancer	0.0088	0.00951	CcSEcCtD
Guaifenesin—Dizziness—Degarelix—prostate cancer	0.00879	0.0095	CcSEcCtD
Guaifenesin—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00876	0.00946	CcSEcCtD
Guaifenesin—Urticaria—Bicalutamide—prostate cancer	0.00854	0.00922	CcSEcCtD
Guaifenesin—Vomiting—Degarelix—prostate cancer	0.00846	0.00913	CcSEcCtD
Guaifenesin—Rash—Degarelix—prostate cancer	0.00839	0.00906	CcSEcCtD
Guaifenesin—Dermatitis—Degarelix—prostate cancer	0.00838	0.00905	CcSEcCtD
Guaifenesin—Headache—Degarelix—prostate cancer	0.00833	0.009	CcSEcCtD
Guaifenesin—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00831	0.00897	CcSEcCtD
Guaifenesin—Dizziness—Cabazitaxel—prostate cancer	0.00828	0.00895	CcSEcCtD
Guaifenesin—Vomiting—Cabazitaxel—prostate cancer	0.00797	0.0086	CcSEcCtD
Guaifenesin—Nausea—Degarelix—prostate cancer	0.0079	0.00853	CcSEcCtD
Guaifenesin—Headache—Cabazitaxel—prostate cancer	0.00785	0.00848	CcSEcCtD
Guaifenesin—Discomfort—Goserelin—prostate cancer	0.00771	0.00832	CcSEcCtD
Guaifenesin—Nausea—Cabazitaxel—prostate cancer	0.00744	0.00804	CcSEcCtD
Guaifenesin—Urticaria—Ethinyl Estradiol—prostate cancer	0.00722	0.00779	CcSEcCtD
Guaifenesin—Dizziness—Bicalutamide—prostate cancer	0.00711	0.00768	CcSEcCtD
Guaifenesin—Vomiting—Bicalutamide—prostate cancer	0.00683	0.00738	CcSEcCtD
Guaifenesin—Rash—Bicalutamide—prostate cancer	0.00678	0.00732	CcSEcCtD
Guaifenesin—Dermatitis—Bicalutamide—prostate cancer	0.00677	0.00731	CcSEcCtD
Guaifenesin—Headache—Bicalutamide—prostate cancer	0.00673	0.00727	CcSEcCtD
Guaifenesin—Nausea—Bicalutamide—prostate cancer	0.00638	0.00689	CcSEcCtD
Guaifenesin—Discomfort—Estradiol—prostate cancer	0.00611	0.0066	CcSEcCtD
Guaifenesin—Dizziness—Ethinyl Estradiol—prostate cancer	0.00601	0.00649	CcSEcCtD
Guaifenesin—Urticaria—Goserelin—prostate cancer	0.00594	0.00641	CcSEcCtD
Guaifenesin—Urticaria—Conjugated Estrogens—prostate cancer	0.00588	0.00635	CcSEcCtD
Guaifenesin—Vomiting—Ethinyl Estradiol—prostate cancer	0.00578	0.00624	CcSEcCtD
Guaifenesin—Rash—Ethinyl Estradiol—prostate cancer	0.00573	0.00619	CcSEcCtD
Guaifenesin—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00572	0.00618	CcSEcCtD
Guaifenesin—Discomfort—Mitoxantrone—prostate cancer	0.00569	0.00615	CcSEcCtD
Guaifenesin—Headache—Ethinyl Estradiol—prostate cancer	0.00569	0.00615	CcSEcCtD
Guaifenesin—Chlorphenesin—CYP19A1—prostate cancer	0.0054	0.0729	CrCbGaD
Guaifenesin—Nausea—Ethinyl Estradiol—prostate cancer	0.0054	0.00583	CcSEcCtD
Guaifenesin—Dizziness—Goserelin—prostate cancer	0.00494	0.00534	CcSEcCtD
Guaifenesin—Dizziness—Conjugated Estrogens—prostate cancer	0.0049	0.00529	CcSEcCtD
Guaifenesin—Vomiting—Goserelin—prostate cancer	0.00475	0.00513	CcSEcCtD
Guaifenesin—Discomfort—Etoposide—prostate cancer	0.00473	0.00511	CcSEcCtD
Guaifenesin—Rash—Goserelin—prostate cancer	0.00471	0.00509	CcSEcCtD
Guaifenesin—Dermatitis—Goserelin—prostate cancer	0.00471	0.00509	CcSEcCtD
Guaifenesin—Vomiting—Conjugated Estrogens—prostate cancer	0.00471	0.00509	CcSEcCtD
Guaifenesin—Urticaria—Estradiol—prostate cancer	0.00471	0.00508	CcSEcCtD
Guaifenesin—Headache—Goserelin—prostate cancer	0.00468	0.00506	CcSEcCtD
Guaifenesin—Rash—Conjugated Estrogens—prostate cancer	0.00467	0.00504	CcSEcCtD
Guaifenesin—Dermatitis—Conjugated Estrogens—prostate cancer	0.00466	0.00504	CcSEcCtD
Guaifenesin—Headache—Conjugated Estrogens—prostate cancer	0.00464	0.00501	CcSEcCtD
Guaifenesin—Penbutolol—ADRB2—prostate cancer	0.00464	0.0626	CrCbGaD
Guaifenesin—Nausea—Goserelin—prostate cancer	0.00444	0.0048	CcSEcCtD
Guaifenesin—Nausea—Conjugated Estrogens—prostate cancer	0.0044	0.00475	CcSEcCtD
Guaifenesin—Urticaria—Mitoxantrone—prostate cancer	0.00439	0.00474	CcSEcCtD
Guaifenesin—Carvedilol—VEGFA—prostate cancer	0.00426	0.0575	CrCbGaD
Guaifenesin—Oxprenolol—ADRB2—prostate cancer	0.00425	0.0573	CrCbGaD
Guaifenesin—Dizziness—Estradiol—prostate cancer	0.00392	0.00423	CcSEcCtD
Guaifenesin—Alprenolol—ADRB2—prostate cancer	0.00388	0.0524	CrCbGaD
Guaifenesin—Discomfort—Capecitabine—prostate cancer	0.00381	0.00411	CcSEcCtD
Guaifenesin—Vomiting—Estradiol—prostate cancer	0.00377	0.00407	CcSEcCtD
Guaifenesin—Rash—Estradiol—prostate cancer	0.00374	0.00404	CcSEcCtD
Guaifenesin—Dermatitis—Estradiol—prostate cancer	0.00373	0.00403	CcSEcCtD
Guaifenesin—Headache—Estradiol—prostate cancer	0.00371	0.00401	CcSEcCtD
Guaifenesin—Urticaria—Etoposide—prostate cancer	0.00365	0.00394	CcSEcCtD
Guaifenesin—Nausea—Estradiol—prostate cancer	0.00352	0.0038	CcSEcCtD
Guaifenesin—Vomiting—Mitoxantrone—prostate cancer	0.00351	0.00379	CcSEcCtD
Guaifenesin—Rash—Mitoxantrone—prostate cancer	0.00348	0.00376	CcSEcCtD
Guaifenesin—Dermatitis—Mitoxantrone—prostate cancer	0.00348	0.00376	CcSEcCtD
Guaifenesin—Headache—Mitoxantrone—prostate cancer	0.00346	0.00374	CcSEcCtD
Guaifenesin—Discomfort—Prednisone—prostate cancer	0.00339	0.00366	CcSEcCtD
Guaifenesin—Pindolol—ADRB2—prostate cancer	0.00334	0.0451	CrCbGaD
Guaifenesin—Nausea—Mitoxantrone—prostate cancer	0.00328	0.00354	CcSEcCtD
Guaifenesin—Dizziness—Etoposide—prostate cancer	0.00304	0.00328	CcSEcCtD
Guaifenesin—Urticaria—Capecitabine—prostate cancer	0.00294	0.00317	CcSEcCtD
Guaifenesin—Vomiting—Etoposide—prostate cancer	0.00292	0.00315	CcSEcCtD
Guaifenesin—Rash—Etoposide—prostate cancer	0.0029	0.00313	CcSEcCtD
Guaifenesin—Dermatitis—Etoposide—prostate cancer	0.00289	0.00313	CcSEcCtD
Guaifenesin—Headache—Etoposide—prostate cancer	0.00288	0.00311	CcSEcCtD
Guaifenesin—Nausea—Etoposide—prostate cancer	0.00273	0.00295	CcSEcCtD
Guaifenesin—Ranolazine—CYP3A4—prostate cancer	0.00266	0.0359	CrCbGaD
Guaifenesin—Discomfort—Epirubicin—prostate cancer	0.00265	0.00287	CcSEcCtD
Guaifenesin—Urticaria—Prednisone—prostate cancer	0.00262	0.00282	CcSEcCtD
Guaifenesin—Chlorphenesin—CYP3A4—prostate cancer	0.00254	0.0343	CrCbGaD
Guaifenesin—Dizziness—Docetaxel—prostate cancer	0.00252	0.00273	CcSEcCtD
Guaifenesin—Chlorphenesin—PTGS2—prostate cancer	0.00248	0.0335	CrCbGaD
Guaifenesin—Discomfort—Doxorubicin—prostate cancer	0.00246	0.00265	CcSEcCtD
Guaifenesin—Dizziness—Capecitabine—prostate cancer	0.00244	0.00264	CcSEcCtD
Guaifenesin—Vomiting—Docetaxel—prostate cancer	0.00243	0.00262	CcSEcCtD
Guaifenesin—Rash—Docetaxel—prostate cancer	0.00241	0.0026	CcSEcCtD
Guaifenesin—Dermatitis—Docetaxel—prostate cancer	0.0024	0.0026	CcSEcCtD
Guaifenesin—Carvedilol—ADRB2—prostate cancer	0.0024	0.0324	CrCbGaD
Guaifenesin—Headache—Docetaxel—prostate cancer	0.00239	0.00258	CcSEcCtD
Guaifenesin—Vomiting—Capecitabine—prostate cancer	0.00235	0.00254	CcSEcCtD
Guaifenesin—Rash—Capecitabine—prostate cancer	0.00233	0.00252	CcSEcCtD
Guaifenesin—Dermatitis—Capecitabine—prostate cancer	0.00233	0.00251	CcSEcCtD
Guaifenesin—Headache—Capecitabine—prostate cancer	0.00232	0.0025	CcSEcCtD
Guaifenesin—Propranolol—CYP3A5—prostate cancer	0.00231	0.0311	CrCbGaD
Guaifenesin—Nausea—Docetaxel—prostate cancer	0.00227	0.00245	CcSEcCtD
Guaifenesin—Nausea—Capecitabine—prostate cancer	0.0022	0.00237	CcSEcCtD
Guaifenesin—Dizziness—Prednisone—prostate cancer	0.00218	0.00235	CcSEcCtD
Guaifenesin—Vomiting—Prednisone—prostate cancer	0.00209	0.00226	CcSEcCtD
Guaifenesin—Carvedilol—CYP2E1—prostate cancer	0.00208	0.0281	CrCbGaD
Guaifenesin—Rash—Prednisone—prostate cancer	0.00208	0.00224	CcSEcCtD
Guaifenesin—Dermatitis—Prednisone—prostate cancer	0.00207	0.00224	CcSEcCtD
Guaifenesin—Headache—Prednisone—prostate cancer	0.00206	0.00223	CcSEcCtD
Guaifenesin—Carvedilol—CYP1A1—prostate cancer	0.00206	0.0277	CrCbGaD
Guaifenesin—Urticaria—Epirubicin—prostate cancer	0.00205	0.00221	CcSEcCtD
Guaifenesin—Nausea—Prednisone—prostate cancer	0.00196	0.00211	CcSEcCtD
Guaifenesin—Urticaria—Doxorubicin—prostate cancer	0.00189	0.00204	CcSEcCtD
Guaifenesin—Propranolol—ADRB2—prostate cancer	0.00182	0.0246	CrCbGaD
Guaifenesin—Dizziness—Epirubicin—prostate cancer	0.0017	0.00184	CcSEcCtD
Guaifenesin—Vomiting—Epirubicin—prostate cancer	0.00164	0.00177	CcSEcCtD
Guaifenesin—Rash—Epirubicin—prostate cancer	0.00162	0.00175	CcSEcCtD
Guaifenesin—Dermatitis—Epirubicin—prostate cancer	0.00162	0.00175	CcSEcCtD
Guaifenesin—Headache—Epirubicin—prostate cancer	0.00161	0.00174	CcSEcCtD
Guaifenesin—Dizziness—Doxorubicin—prostate cancer	0.00158	0.0017	CcSEcCtD
Guaifenesin—Propranolol—CYP2C19—prostate cancer	0.00157	0.0212	CrCbGaD
Guaifenesin—Propranolol—CYP1A1—prostate cancer	0.00156	0.0211	CrCbGaD
Guaifenesin—Nausea—Epirubicin—prostate cancer	0.00153	0.00165	CcSEcCtD
Guaifenesin—Vomiting—Doxorubicin—prostate cancer	0.00151	0.00164	CcSEcCtD
Guaifenesin—Rash—Doxorubicin—prostate cancer	0.0015	0.00162	CcSEcCtD
Guaifenesin—Dermatitis—Doxorubicin—prostate cancer	0.0015	0.00162	CcSEcCtD
Guaifenesin—Headache—Doxorubicin—prostate cancer	0.00149	0.00161	CcSEcCtD
Guaifenesin—Nausea—Doxorubicin—prostate cancer	0.00142	0.00153	CcSEcCtD
Guaifenesin—Carvedilol—CYP3A4—prostate cancer	0.00131	0.0177	CrCbGaD
Guaifenesin—Propranolol—CYP3A4—prostate cancer	0.000998	0.0135	CrCbGaD
